CARING FOR PATIENTS WITH CANCER:@0.084848:0.038601:0.499679:0.038601:0.499679:0.019343:0.084848:0.019343:0.019121:0.017404:0.014276:0.005315:0.017404:0.020508:0.006515:0.011406:0.020438:0.014276:0.006515:0.012154:0.015492:0.010019:0.005315:0.012606:0.017404:0.010019:0.011712:0.006515:0.022578:0.005315:0.010019:0.016063:0.006515:0.019121:0.017404:0.017404:0.019121:0.012606:0.014276
112:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Source: MA  SCC Index: Courtesy of the NCCN Guidelines Version 1.2018; :@0.083636:0.591231:0.607050:0.591231:0.607050:0.578976:0.083636:0.578976:0.007453:0.009803:0.009100:0.004505:0.009683:0.009728:0.004146:0.004146:0.013754:0.011075:0.000000:0.000000:0.007453:0.012168:0.012168:0.004146:0.003382:0.009129:0.010252:0.009728:0.007184:0.004146:0.004146:0.012168:0.009803:0.009100:0.004505:0.005074:0.009728:0.005807:0.008022:0.004146:0.009803:0.004699:0.004146:0.005074:0.009129:0.009728:0.004146:0.011075:0.012168:0.012168:0.011075:0.004146:0.013051:0.009100:0.002993:0.010252:0.009728:0.002993:0.002993:0.009129:0.009728:0.005807:0.004146:0.010506:0.009728:0.004505:0.005807:0.002993:0.009803:0.009129:0.004146:0.008291:0.004146:0.008291:0.008291:0.008291:0.008291:0.004146:0.004146
Prevention and Treatment of :@0.607023:0.591231:0.818241:0.591231:0.818241:0.578976:0.607023:0.578976:0.008860:0.004441:0.009728:0.008291:0.009728:0.009129:0.005074:0.002993:0.009803:0.009129:0.004146:0.010222:0.009129:0.010252:0.004146:0.005916:0.004443:0.009728:0.010222:0.005074:0.014038:0.009728:0.009129:0.005074:0.004146:0.009803:0.004699:0.004146
Cancer-Related Infections:@0.083636:0.604463:0.274696:0.604463:0.274696:0.592208:0.083636:0.592208:0.012168:0.010222:0.009129:0.009683:0.009728:0.004505:0.004969:0.009085:0.009728:0.002993:0.010222:0.005074:0.009728:0.010252:0.004146:0.003382:0.009129:0.004699:0.009728:0.009683:0.005074:0.002993:0.009803:0.009129:0.005807
, FEV-D.:@0.274681:0.604463:0.329009:0.604463:0.329009:0.592208:0.274681:0.592208:0.004146:0.004146:0.007259:0.008022:0.010506:0.004969:0.011135:0.004146
8,13:@0.329009:0.600090:0.345928:0.600090:0.345928:0.592945:0.329009:0.592945:0.004834:0.002417:0.004834:0.004834
Figure 1. Risk assessment resources:@0.084848:0.096562:0.387335:0.096562:0.387335:0.080172:0.084848:0.080172:0.009756:0.005272:0.011257:0.011218:0.007158:0.010160:0.003887:0.010680:0.005003:0.003887:0.011601:0.005272:0.008351:0.010429:0.003887:0.010160:0.008351:0.008351:0.010160:0.008351:0.008351:0.016548:0.010160:0.011159:0.007062:0.003887:0.007158:0.010160:0.008351:0.011103:0.011218:0.007158:0.008467:0.010160:0.008351
Using the MASCC risk-index score:@0.126544:0.146118:0.393802:0.146118:0.393802:0.130976:0.126544:0.130976:0.010468:0.007197:0.003925:0.009814:0.010795:0.004580:0.004907:0.009814:0.010468:0.004580:0.014720:0.012103:0.008505:0.012758:0.012758:0.004580:0.005234:0.003925:0.007197:0.009487:0.006870:0.003925:0.009814:0.010795:0.010468:0.009159:0.004580:0.007197:0.010468:0.010468:0.005234:0.010468
n   :@0.126544:0.159183:0.151133:0.159183:0.151133:0.150743:0.126544:0.150743:0.008786:0.003210:0.009383:0.003210
Using the visual analogue score, estimate the patient’s burden of illness at the time of the :@0.147925:0.162140:0.856876:0.162140:0.856876:0.147260:0.147925:0.147260:0.010713:0.006346:0.003271:0.009977:0.011008:0.004531:0.005545:0.009977:0.010631:0.004531:0.009061:0.003271:0.006346:0.009944:0.011171:0.003271:0.004531:0.011171:0.009977:0.011171:0.003271:0.010713:0.011008:0.009944:0.010631:0.004531:0.006346:0.010582:0.010713:0.004856:0.010631:0.004531:0.004531:0.010631:0.006346:0.005545:0.003271:0.015342:0.011171:0.005545:0.010631:0.004531:0.005545:0.009977:0.010631:0.004531:0.011155:0.011171:0.005545:0.003271:0.010631:0.009977:0.005545:0.005741:0.006346:0.004531:0.011155:0.009944:0.004825:0.011204:0.010631:0.009977:0.004531:0.010713:0.005136:0.004531:0.003271:0.003271:0.003271:0.009977:0.010631:0.006346:0.006346:0.004531:0.011171:0.005545:0.004531:0.005545:0.009977:0.010631:0.004531:0.005545:0.003271:0.015342:0.010631:0.004531:0.010713:0.005136:0.004531:0.005545:0.009977:0.010631:0.004531
intitial clinical evaluation. No signs or symptoms or mild signs or symptoms are scored as 5 :@0.147925:0.176834:0.853814:0.176834:0.853814:0.161953:0.147925:0.161953:0.003271:0.009977:0.005545:0.003271:0.005545:0.003271:0.011171:0.003271:0.004531:0.010582:0.003271:0.003271:0.009977:0.003271:0.010582:0.011171:0.003271:0.004531:0.010631:0.009061:0.011171:0.003271:0.009944:0.011171:0.005545:0.003271:0.010713:0.009977:0.004531:0.004531:0.012103:0.010713:0.004531:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.004531:0.010713:0.004923:0.004531:0.015342:0.003271:0.003271:0.011204:0.004531:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.004531:0.011171:0.004854:0.010631:0.004531:0.006346:0.010582:0.010713:0.004856:0.010631:0.011204:0.004531:0.011171:0.006346:0.004531:0.009061:0.004531
points; moderate signs or symptoms are scored as 3 points. These are mutually exclusive. No :@0.147925:0.191527:0.876237:0.191527:0.876237:0.176646:0.147925:0.176646:0.011155:0.010713:0.003271:0.009977:0.005545:0.006346:0.004531:0.004531:0.015342:0.010713:0.011204:0.010631:0.004923:0.011171:0.005545:0.010631:0.004531:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.004531:0.011171:0.004856:0.010631:0.004531:0.006346:0.010582:0.010713:0.004856:0.010631:0.011204:0.004531:0.011171:0.006346:0.004531:0.009061:0.004531:0.011155:0.010713:0.003271:0.009977:0.005545:0.006346:0.004531:0.004531:0.006968:0.009977:0.010631:0.006346:0.010631:0.004531:0.011171:0.004854:0.010631:0.004531:0.015342:0.009944:0.005545:0.009944:0.011171:0.003271:0.003271:0.008767:0.004531:0.010631:0.007851:0.010582:0.003271:0.009944:0.006346:0.003271:0.009061:0.010631:0.004531:0.004531:0.012103:0.010713:0.004531
points are scored for severe signs or symptoms or moribund.:@0.147925:0.206220:0.618465:0.206220:0.618465:0.191339:0.147925:0.191339:0.011155:0.010713:0.003271:0.009977:0.005545:0.006346:0.004531:0.011171:0.004854:0.010631:0.004531:0.006346:0.010582:0.010713:0.004856:0.010631:0.011204:0.004531:0.005136:0.010713:0.004923:0.004531:0.006346:0.010631:0.009061:0.010631:0.004856:0.010631:0.004531:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.004531:0.010713:0.004923:0.004531:0.015342:0.010713:0.004923:0.003271:0.011155:0.009944:0.009977:0.011204:0.004531
n   :@0.126544:0.219302:0.151133:0.219302:0.151133:0.210862:0.126544:0.210862:0.008786:0.003210:0.009383:0.003210
Based on the patient’s age, past medical history, present clinical features, and site of care :@0.147925:0.222260:0.866521:0.222260:0.866521:0.207379:0.147925:0.207379:0.009388:0.011171:0.006346:0.010631:0.011204:0.004531:0.010713:0.009977:0.004531:0.005545:0.009977:0.010631:0.004531:0.011155:0.011171:0.005545:0.003271:0.010631:0.009977:0.005545:0.005741:0.006346:0.004531:0.011171:0.011008:0.010631:0.004531:0.004531:0.011155:0.011171:0.006346:0.005545:0.004531:0.015342:0.010631:0.011204:0.003271:0.010582:0.011171:0.003271:0.004531:0.009977:0.003271:0.006346:0.005545:0.010713:0.004923:0.008767:0.004531:0.004531:0.011155:0.004856:0.010631:0.006346:0.010631:0.009977:0.005545:0.004531:0.010582:0.003271:0.003271:0.009977:0.003271:0.010582:0.011171:0.003271:0.004531:0.005136:0.010631:0.011171:0.005545:0.009944:0.004856:0.010631:0.006346:0.004531:0.004531:0.011171:0.009977:0.011204:0.004531:0.006346:0.003271:0.005545:0.010631:0.004531:0.010713:0.005136:0.004531:0.010582:0.011171:0.004854:0.010631:0.004531
(input/output when febrile episode occured), score the other factors in the model and total :@0.147925:0.236953:0.878154:0.236953:0.878154:0.222072:0.147925:0.222072:0.006035:0.003271:0.009977:0.011155:0.009944:0.005545:0.007148:0.010713:0.009944:0.005545:0.011155:0.009944:0.005545:0.004531:0.013592:0.009977:0.010631:0.009977:0.004531:0.005136:0.010631:0.011155:0.004923:0.003271:0.003271:0.010631:0.004531:0.010631:0.011155:0.003271:0.006346:0.010713:0.011204:0.010631:0.004531:0.010713:0.010582:0.010582:0.009944:0.004856:0.010631:0.011204:0.006035:0.004531:0.004531:0.006346:0.010582:0.010713:0.004856:0.010631:0.004531:0.005545:0.009977:0.010631:0.004531:0.010713:0.005545:0.009977:0.010631:0.004923:0.004531:0.005136:0.011171:0.010582:0.005545:0.010713:0.004923:0.006346:0.004531:0.003271:0.009977:0.004531:0.005545:0.009977:0.010631:0.004531:0.015342:0.010713:0.011204:0.010631:0.003271:0.004531:0.011171:0.009977:0.011204:0.004531:0.005545:0.010713:0.005545:0.011171:0.003271:0.004531
the sum.:@0.147925:0.251646:0.214772:0.251646:0.214772:0.236765:0.147925:0.236765:0.005545:0.009977:0.010631:0.004531:0.006346:0.009944:0.015342:0.004531
Burden of illnes:@0.126433:0.290341:0.245505:0.290341:0.245505:0.275198:0.126433:0.275198:0.009487:0.009814:0.005234:0.010795:0.010468:0.009814:0.004580:0.010468:0.004580:0.004580:0.003925:0.003925:0.003925:0.009814:0.010468:0.007197
How sick is the patient at presentation?:@0.126433:0.305034:0.436771:0.305034:0.436771:0.290154:0.126433:0.290154:0.011171:0.010713:0.013592:0.004531:0.006346:0.003271:0.010582:0.008211:0.004531:0.003271:0.006346:0.004531:0.005545:0.009977:0.010631:0.004531:0.011155:0.011171:0.005545:0.003271:0.010631:0.009977:0.005545:0.004531:0.011171:0.005545:0.004531:0.011155:0.004856:0.010631:0.006346:0.010631:0.009977:0.005545:0.011171:0.005545:0.003271:0.010713:0.009977:0.009667
Estimate the burden of illness considering :@0.216228:0.393231:0.544786:0.393231:0.544786:0.378350:0.216228:0.378350:0.008767:0.006346:0.005545:0.003271:0.015342:0.011171:0.005545:0.010631:0.004531:0.005545:0.009977:0.010631:0.004531:0.011155:0.009944:0.004823:0.011204:0.010631:0.009977:0.004531:0.010713:0.005136:0.004531:0.003271:0.003271:0.003271:0.009977:0.010631:0.006346:0.006346:0.004531:0.010582:0.010713:0.009977:0.006346:0.003271:0.011204:0.010631:0.004923:0.003271:0.009977:0.011008:0.004531
all comorbid conditions:@0.285103:0.407924:0.471382:0.407924:0.471382:0.393043:0.285103:0.393043:0.011171:0.003271:0.003271:0.004531:0.010582:0.010713:0.015342:0.010713:0.004923:0.011155:0.003271:0.011204:0.004531:0.010582:0.010713:0.009977:0.011204:0.003271:0.005545:0.003271:0.010713:0.009977:0.006346
MASCC risk-index score/:@0.651770:0.297819:0.850005:0.297819:0.850005:0.282676:0.651770:0.282676:0.014720:0.012103:0.008505:0.012758:0.012758:0.004580:0.005234:0.003925:0.007197:0.009487:0.006870:0.003925:0.009814:0.010795:0.010468:0.009159:0.004580:0.007197:0.010468:0.010468:0.005234:0.010468:0.007524
model:@0.651770:0.312512:0.702800:0.312512:0.702800:0.297369:0.651770:0.297369:0.015375:0.010468:0.010795:0.010468:0.003925
1,2:@0.702802:0.307211:0.716961:0.307211:0.716961:0.298536:0.702802:0.298536:0.005283:0.003594:0.005283
Characteristic:@0.651770:0.327217:0.762664:0.327217:0.762664:0.312074:0.651770:0.312074:0.012758:0.009814:0.010795:0.005234:0.010795:0.010468:0.004907:0.010468:0.005234:0.003925:0.007197:0.004907:0.003925:0.010468
Weight:@0.824964:0.327217:0.879593:0.327217:0.879593:0.312074:0.824964:0.312074:0.014720:0.010468:0.003925:0.010795:0.009814:0.004907
n   :@0.651770:0.340282:0.676358:0.340282:0.676358:0.331841:0.651770:0.331841:0.008786:0.003210:0.009383:0.003210
Burden of illness:@0.673150:0.343239:0.797144:0.343239:0.797144:0.328358:0.673150:0.328358:0.009388:0.009944:0.004823:0.011204:0.010631:0.009977:0.004531:0.010713:0.005136:0.004531:0.003271:0.003271:0.003271:0.009977:0.010631:0.006346:0.006346
  -  No or mild :@0.651773:0.357932:0.773252:0.357932:0.773252:0.343052:0.651773:0.343052:0.004531:0.016850:0.005430:0.004531:0.005005:0.012103:0.010713:0.004531:0.010713:0.004923:0.004531:0.015342:0.003271:0.003271:0.011204:0.004531
   symptoms :@0.651773:0.372625:0.772205:0.372625:0.772205:0.357745:0.651773:0.357745:0.004531:0.016850:0.014966:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.004531
5:@0.824949:0.372625:0.834010:0.372625:0.834010:0.357745:0.824949:0.357745:0.009061
  - Moderate :@0.651773:0.387319:0.772500:0.387319:0.772500:0.372438:0.651773:0.372438:0.004531:0.016850:0.005430:0.009535:0.015031:0.010713:0.011204:0.010631:0.004923:0.011171:0.005545:0.010631:0.004531
   symptoms :@0.651773:0.402012:0.772205:0.402012:0.772205:0.387131:0.651773:0.387131:0.004531:0.016850:0.014966:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.004531
3:@0.824949:0.402012:0.834010:0.402012:0.834010:0.387131:0.824949:0.387131:0.009061
n   :@0.651770:0.415100:0.676358:0.415100:0.676358:0.406660:0.651770:0.406660:0.008786:0.003210:0.009383:0.003210
No hypotension:@0.673150:0.418058:0.797571:0.418058:0.797571:0.403177:0.673150:0.403177:0.012103:0.010713:0.004531:0.009977:0.008767:0.011155:0.010713:0.005545:0.010631:0.009977:0.006346:0.003271:0.010713:0.009977
 :@0.797553:0.415100:0.773365:0.415100:0.773365:0.406660:0.797553:0.406660:-0.024188
 :@0.824950:0.415100:0.800763:0.415100:0.800763:0.406660:0.824950:0.406660:-0.024188
5:@0.824951:0.418058:0.834012:0.418058:0.834012:0.403177:0.824951:0.403177:0.009061
n   :@0.651770:0.431122:0.676358:0.431122:0.676358:0.422682:0.651770:0.422682:0.008786:0.003210:0.009383:0.003210
No COPD :@0.673150:0.434080:0.754391:0.434080:0.754391:0.419199:0.673150:0.419199:0.012103:0.010713:0.004531:0.013297:0.014214:0.009683:0.012169:0.004531
4:@0.824962:0.434080:0.834023:0.434080:0.834023:0.419199:0.824962:0.419199:0.009061
n   :@0.651770:0.447144:0.676358:0.447144:0.676358:0.438704:0.651770:0.438704:0.008786:0.003210:0.009383:0.003210
Solid or tumour or :@0.673150:0.450101:0.815562:0.450101:0.815562:0.435221:0.673150:0.435221:0.008145:0.010713:0.003271:0.003271:0.011204:0.004531:0.010713:0.004923:0.004531:0.005545:0.009944:0.015342:0.010713:0.009944:0.004923:0.004531:0.010713:0.004923:0.004531
haematologic :@0.673150:0.464795:0.791077:0.464795:0.791077:0.449914:0.673150:0.449914:0.009977:0.011171:0.010631:0.015342:0.011171:0.005545:0.010713:0.003271:0.010713:0.011008:0.003271:0.010582:0.004531
malignancy with no :@0.673150:0.479488:0.834355:0.479488:0.834355:0.464607:0.673150:0.464607:0.015342:0.011171:0.003271:0.003271:0.011008:0.009977:0.011171:0.009977:0.010582:0.008767:0.004531:0.013592:0.003271:0.005545:0.009977:0.004531:0.009977:0.010713:0.004531
previous fungal :@0.673150:0.494181:0.798697:0.494181:0.798697:0.479300:0.673150:0.479300:0.011155:0.004856:0.010631:0.009061:0.003271:0.010713:0.009944:0.006346:0.004531:0.005136:0.009944:0.009977:0.011008:0.011171:0.003271:0.004531
infection:@0.673150:0.510199:0.742254:0.510199:0.742254:0.495318:0.673150:0.495318:0.003271:0.009977:0.005136:0.010631:0.010582:0.005545:0.003271:0.010713:0.009977
 :@0.742248:0.507263:0.662746:0.507263:0.662746:0.498823:0.742248:0.498823:-0.079502
 :@0.824951:0.507263:0.745449:0.507263:0.745449:0.498823:0.824951:0.498823:-0.079502
4:@0.824951:0.510221:0.834012:0.510221:0.834012:0.495340:0.824951:0.495340:0.009061
n   :@0.651770:0.523285:0.676358:0.523285:0.676358:0.514845:0.651770:0.514845:0.008786:0.003210:0.009383:0.003210
No dehydration:@0.673150:0.526243:0.797881:0.526243:0.797881:0.511362:0.673150:0.511362:0.012103:0.010713:0.004531:0.011204:0.010631:0.009977:0.008767:0.011204:0.004923:0.011171:0.005545:0.003271:0.010713:0.009977
 :@0.797865:0.523285:0.773989:0.523285:0.773989:0.514845:0.797865:0.514845:-0.023876
 :@0.824950:0.523285:0.801074:0.523285:0.801074:0.514845:0.824950:0.514845:-0.023876
3:@0.824951:0.526243:0.834012:0.526243:0.834012:0.511362:0.824951:0.511362:0.009061
n   :@0.651770:0.539307:0.676358:0.539307:0.676358:0.530867:0.651770:0.530867:0.008786:0.003210:0.009383:0.003210
Outpatient status  3:@0.673150:0.542265:0.834015:0.542265:0.834015:0.527384:0.673150:0.527384:0.014214:0.009944:0.005545:0.011155:0.011171:0.005545:0.003271:0.010631:0.009977:0.005545:0.004531:0.006346:0.005545:0.011171:0.005545:0.009944:0.006346:0.004531:0.010847:0.009061
n   :@0.651770:0.555329:0.676358:0.555329:0.676358:0.546889:0.651770:0.546889:0.008786:0.003210:0.009383:0.003210
Age <60 years :@0.673150:0.558287:0.790357:0.558287:0.790357:0.543406:0.673150:0.543406:0.012103:0.011008:0.010631:0.004531:0.009912:0.009061:0.009061:0.004531:0.008767:0.010631:0.011171:0.004923:0.006346:0.004531
2:@0.824957:0.558287:0.834018:0.558287:0.834018:0.543406:0.824957:0.543406:0.009061
No signs or  Mild signs or Moderate :@0.126544:0.343604:0.413528:0.343604:0.413528:0.328724:0.126544:0.328724:0.012103:0.010713:0.004531:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531:0.015914:0.015031:0.003271:0.003271:0.011204:0.004531:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.003271:0.015031:0.010713:0.011204:0.010631:0.004923:0.011171:0.005545:0.010631:0.004531
symptoms:@0.126544:0.358298:0.206100:0.358298:0.206100:0.343417:0.126544:0.343417:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346
symptoms signs or :@0.231452:0.358298:0.390793:0.358298:0.390793:0.343417:0.231452:0.343417:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346:0.018139:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531
symptoms:@0.329147:0.372991:0.408703:0.372991:0.408703:0.358110:0.329147:0.358110:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346
Severe :@0.434316:0.343592:0.492804:0.343592:0.492804:0.328711:0.434316:0.328711:0.008145:0.010631:0.009061:0.010631:0.004856:0.010631:0.004531
signs or :@0.434316:0.358285:0.495962:0.358285:0.495962:0.343404:0.434316:0.343404:0.006346:0.003271:0.011008:0.009977:0.006346:0.004531:0.010713:0.004923:0.004531
symptoms:@0.434316:0.372978:0.513872:0.372978:0.513872:0.358098:0.434316:0.358098:0.006346:0.008767:0.015342:0.011155:0.005545:0.010713:0.015342:0.006346
Moribund:@0.539486:0.343579:0.615705:0.343579:0.615705:0.328699:0.539486:0.328699:0.015031:0.010713:0.004923:0.003271:0.011155:0.009944:0.009977:0.011204
MANAGEMENT:@0.085383:0.643732:0.236329:0.643732:0.236329:0.625916:0.085383:0.625916:0.019242:0.015822:0.015822:0.015822:0.017960:0.011118:0.019242:0.011118:0.015822:0.008980
Management  is symptomatic,  as well as :@0.085383:0.661047:0.484636:0.661047:0.484636:0.645291:0.085383:0.645291:0.017684:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.004216:0.003848:0.007466:0.009563:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330:0.005330:0.004224:0.013143:0.007466:0.009563:0.015990:0.012508:0.003848:0.003848:0.009563:0.013143:0.007466:0.005330
being directed  at the  underlying cause. :@0.085383:0.677213:0.484667:0.677213:0.484667:0.661457:0.085383:0.661457:0.013123:0.012508:0.003848:0.011738:0.012950:0.009852:0.013181:0.003848:0.005717:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.004508:0.013143:0.006523:0.009852:0.006523:0.011738:0.012508:0.005330:0.004508:0.011699:0.011738:0.013181:0.012508:0.005782:0.003848:0.010314:0.003848:0.011738:0.012950:0.009852:0.012450:0.013143:0.011699:0.007466:0.012508:0.005330:0.005330
Hypercalcaemia should be verifi ed by bio-:@0.085383:0.693379:0.479319:0.693379:0.479319:0.677623:0.085383:0.677623:0.013143:0.010314:0.013123:0.012508:0.005661:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.004641:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.004632:0.013123:0.012508:0.004632:0.010660:0.012508:0.005792:0.003848:0.004686:0.000000:0.004684:0.012508:0.013181:0.004632:0.013123:0.010314:0.004635:0.013123:0.003848:0.012604:0.006388
chemistry, consisting  of corrected serum :@0.085383:0.709545:0.484665:0.709545:0.484665:0.693789:0.085383:0.693789:0.012450:0.011738:0.012508:0.018049:0.003848:0.007466:0.006523:0.005792:0.010314:0.005330:0.010352:0.012450:0.012604:0.011738:0.007466:0.003848:0.007466:0.006523:0.003848:0.011738:0.012950:0.005330:0.005036:0.012604:0.006042:0.010352:0.012450:0.012604:0.005792:0.005703:0.012508:0.012450:0.006523:0.012508:0.013181:0.010352:0.007466:0.012508:0.005792:0.011699:0.018049:0.005330
calcium and serum albumin. Saline diuresis :@0.085383:0.725711:0.484624:0.725711:0.484624:0.709955:0.085383:0.709955:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.004734:0.013143:0.011738:0.013181:0.004734:0.007466:0.012508:0.005792:0.011699:0.018049:0.004734:0.013143:0.003848:0.013123:0.011699:0.018049:0.003848:0.011738:0.005330:0.004734:0.009583:0.013143:0.003848:0.003848:0.011738:0.012508:0.004734:0.013181:0.003848:0.011699:0.005715:0.012508:0.007466:0.003848:0.007466:0.005330
is the cornerstone of management. For pa-:@0.085383:0.741877:0.479336:0.741877:0.479336:0.726121:0.085383:0.726121:0.003848:0.007466:0.004176:0.006523:0.011738:0.012508:0.004176:0.012450:0.012604:0.006192:0.011738:0.012508:0.005792:0.007466:0.006523:0.012592:0.011738:0.012508:0.004176:0.012604:0.006042:0.004176:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.004176:0.009333:0.012604:0.005792:0.004176:0.013123:0.013143:0.006388
tients with adequate renal function, 3-4 L :@0.085383:0.758043:0.484665:0.758043:0.484665:0.742287:0.085383:0.742287:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007647:0.015990:0.003848:0.006523:0.011738:0.007649:0.013143:0.013181:0.012508:0.013123:0.011699:0.013143:0.006523:0.012508:0.007647:0.005713:0.012508:0.011738:0.013143:0.003848:0.007658:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.007637:0.010660:0.006388:0.010660:0.007658:0.008890:0.005330
normal  saline  fl uids  per  24  hours  are  re-:@0.085383:0.774209:0.479325:0.774209:0.479325:0.758453:0.085383:0.758453:0.011738:0.012604:0.006317:0.018049:0.013143:0.003848:0.005330:0.004980:0.007466:0.013143:0.003848:0.003848:0.011738:0.012508:0.005330:0.004984:0.004666:0.000000:0.004664:0.011699:0.003848:0.013181:0.007466:0.005330:0.004982:0.013123:0.012508:0.005792:0.005330:0.004972:0.010660:0.010660:0.005330:0.004982:0.011738:0.012604:0.011699:0.005792:0.007466:0.005330:0.004968:0.013143:0.005715:0.012508:0.005330:0.004972:0.005713:0.012508:0.006388
quired and a urine output of 100-150 ml/hr :@0.085383:0.790375:0.484672:0.790375:0.484672:0.774619:0.085383:0.774619:0.013123:0.011699:0.003848:0.005717:0.012508:0.013181:0.005446:0.013143:0.011738:0.013181:0.005446:0.013143:0.005446:0.011699:0.005792:0.003848:0.011738:0.012508:0.005432:0.012604:0.011699:0.006523:0.013123:0.011699:0.006523:0.005428:0.012604:0.006042:0.005434:0.010660:0.010660:0.010660:0.006388:0.010660:0.010660:0.010660:0.005457:0.018049:0.003848:0.008409:0.011738:0.005792:0.005330
should be  encouraged.  Drugs adding to :@0.085383:0.806541:0.484684:0.806541:0.484684:0.790785:0.085383:0.790785:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.008909:0.013123:0.012508:0.005330:0.003569:0.012508:0.011738:0.012450:0.012604:0.011699:0.005792:0.013143:0.012950:0.012508:0.013181:0.005330:0.005330:0.003552:0.014316:0.005792:0.011699:0.012950:0.007466:0.008909:0.013143:0.013181:0.013181:0.003848:0.011738:0.012950:0.008909:0.006523:0.012604:0.005330
calcium conservation, such as thiazide :@0.085383:0.822707:0.484643:0.822707:0.484643:0.806951:0.085383:0.806951:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.013778:0.012450:0.012604:0.011738:0.007466:0.012508:0.005792:0.010660:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.013778:0.007466:0.011699:0.012450:0.011738:0.013778:0.013143:0.007466:0.013778:0.006523:0.011738:0.003848:0.013143:0.008178:0.003848:0.013181:0.012508:0.005330
diuretics and calcium supplementation, :@0.085383:0.838873:0.484643:0.838873:0.484643:0.823118:0.085383:0.823118:0.013181:0.003848:0.011699:0.005715:0.012508:0.006523:0.003848:0.012450:0.007466:0.013123:0.013143:0.011738:0.013181:0.013123:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.013123:0.007466:0.011699:0.013123:0.013123:0.003848:0.012508:0.018049:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330
should be discontinued. Furosemide may :@0.085383:0.855040:0.484655:0.855040:0.484655:0.839284:0.085383:0.839284:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.008313:0.013123:0.012508:0.008313:0.013181:0.003848:0.007466:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.011699:0.012508:0.013181:0.005330:0.008313:0.009333:0.011699:0.005707:0.012604:0.007466:0.012508:0.018049:0.003848:0.013181:0.012508:0.008313:0.018049:0.013143:0.010314:0.005330
be administered to encourage a calcium :@0.085383:0.871206:0.484659:0.871206:0.484659:0.855450:0.085383:0.855450:0.013123:0.012508:0.006696:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007466:0.006523:0.012508:0.005717:0.012508:0.013181:0.006696:0.006523:0.012604:0.006687:0.012508:0.011738:0.012450:0.012604:0.011699:0.005792:0.013143:0.012935:0.012508:0.006696:0.013143:0.006696:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.005330
diuresis; only  once  adequate  hydration :@0.085383:0.887372:0.484663:0.887372:0.484663:0.871616:0.085383:0.871616:0.013181:0.003848:0.011699:0.005715:0.012508:0.007466:0.003848:0.007466:0.005330:0.012604:0.012604:0.011738:0.003848:0.010314:0.005330:0.007264:0.012604:0.011738:0.012450:0.012508:0.005330:0.007254:0.013143:0.013181:0.012508:0.013123:0.011699:0.013143:0.006523:0.012508:0.005330:0.007264:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
is obtained.  Regular  monitoring  of  renal :@0.085383:0.903538:0.484653:0.903538:0.484653:0.887782:0.085383:0.887782:0.003848:0.007466:0.010757:0.012604:0.013123:0.006523:0.013143:0.003848:0.011738:0.012508:0.013181:0.005330:0.005330:0.005411:0.011680:0.012508:0.012950:0.011699:0.003848:0.013143:0.005792:0.005330:0.005415:0.018049:0.012604:0.011738:0.003848:0.006523:0.012604:0.005792:0.003848:0.011738:0.012950:0.005330:0.005401:0.012604:0.006042:0.005330:0.005413:0.005713:0.012508:0.011738:0.013143:0.003848:0.005330
function is required. For patients with cal-:@0.085383:0.919704:0.479308:0.919704:0.479308:0.903948:0.085383:0.903948:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.007628:0.003848:0.007466:0.007639:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.005330:0.007639:0.009333:0.012604:0.005792:0.007628:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007639:0.015990:0.003848:0.006523:0.011738:0.007639:0.012450:0.013143:0.003848:0.006388
cium levels of 3 mmol/L or higher, or with :@0.085383:0.935870:0.484645:0.935870:0.484645:0.920114:0.085383:0.920114:0.012450:0.003848:0.011699:0.018049:0.007639:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466:0.007651:0.012604:0.006042:0.007639:0.010660:0.007639:0.018049:0.018049:0.012604:0.003848:0.008409:0.008890:0.007639:0.012604:0.005792:0.007639:0.011738:0.003848:0.012950:0.011738:0.012508:0.003762:0.005330:0.007639:0.012604:0.005792:0.007639:0.015990:0.003848:0.006523:0.011738:0.005330
clinical symptoms due to hypercalcaemia, :@0.521743:0.643730:0.921013:0.643730:0.921013:0.627974:0.521743:0.627974:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.004360:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.004349:0.013181:0.011699:0.012508:0.004349:0.006523:0.012604:0.004349:0.011738:0.010314:0.013123:0.012508:0.005655:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330
bisphosphonates should be administered. :@0.521743:0.659896:0.921007:0.659896:0.921007:0.644140:0.521743:0.644140:0.013123:0.003848:0.007466:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.011738:0.013143:0.006523:0.012508:0.007466:0.007505:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.007505:0.013123:0.012508:0.007505:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007466:0.006523:0.012508:0.005719:0.012508:0.013181:0.005330:0.005330
The dose and choice of agent will depend :@0.521743:0.676062:0.921021:0.676062:0.921021:0.660306:0.521743:0.660306:0.008197:0.011738:0.012508:0.004680:0.013181:0.012604:0.007466:0.012508:0.004686:0.013143:0.011738:0.013181:0.004695:0.012450:0.011738:0.012604:0.003848:0.012450:0.012508:0.004682:0.012604:0.006042:0.004684:0.013143:0.012950:0.012508:0.011738:0.006523:0.004686:0.015990:0.003848:0.003848:0.003848:0.004695:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.005330
on the patient’s renal function and physi-:@0.521743:0.692228:0.915695:0.692228:0.915695:0.676472:0.521743:0.676472:0.012604:0.011738:0.007106:0.006523:0.011738:0.012508:0.007108:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.006754:0.007466:0.007120:0.005713:0.012508:0.011738:0.013143:0.003848:0.007120:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.007110:0.013143:0.011738:0.013181:0.007120:0.013123:0.011738:0.010314:0.007466:0.003848:0.006388
cian preference. Calcitonin, a physiologi-:@0.521743:0.708394:0.915668:0.708394:0.915668:0.692638:0.521743:0.692638:0.012450:0.003848:0.013143:0.011738:0.007505:0.013123:0.005715:0.012508:0.006042:0.012508:0.005709:0.012508:0.011738:0.012450:0.012508:0.005330:0.007505:0.015644:0.013143:0.003848:0.012450:0.003848:0.006523:0.012604:0.011738:0.003848:0.011738:0.005330:0.007505:0.013143:0.007505:0.013123:0.011738:0.010314:0.007466:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.006388
cal PTH antagonist,  has been shown  to :@0.521743:0.724560:0.921040:0.724560:0.921040:0.708804:0.521743:0.708804:0.012450:0.013143:0.003848:0.010987:0.011392:0.008197:0.013143:0.010987:0.013143:0.011738:0.006523:0.013143:0.012950:0.012604:0.011738:0.003848:0.007466:0.006523:0.005330:0.005330:0.005648:0.011738:0.013143:0.007466:0.010987:0.013123:0.012508:0.012508:0.011738:0.010987:0.007466:0.011738:0.012604:0.015990:0.011738:0.005330:0.005646:0.006523:0.012604:0.005330
decrease serum  calcium in patients with :@0.521743:0.740726:0.921027:0.740726:0.921027:0.724970:0.521743:0.724970:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.008986:0.007466:0.012508:0.005792:0.011699:0.018049:0.005330:0.003645:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.008986:0.003848:0.011738:0.008986:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008986:0.015990:0.003848:0.006523:0.011738:0.005330
malignant hypercalcaemia, and salmon :@0.521743:0.756892:0.921002:0.756892:0.921002:0.741136:0.521743:0.741136:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.010930:0.011738:0.010314:0.013123:0.012508:0.005655:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.010930:0.013143:0.011738:0.013181:0.010930:0.007466:0.013143:0.003848:0.018049:0.012604:0.011738:0.005330
calcitonin (Miacalcic ) is registered  for :@0.521743:0.773058:0.921029:0.773127:0.921029:0.757372:0.521743:0.757302:0.012450:0.013143:0.003848:0.012450:0.003848:0.006523:0.012604:0.011738:0.003848:0.011738:0.014413:0.007100:0.017684:0.003848:0.013143:0.012450:0.013143:0.003848:0.012450:0.003848:0.012450:0.008392:0.007100:0.014413:0.003848:0.007466:0.014413:0.005713:0.012508:0.012950:0.003848:0.007466:0.006523:0.012508:0.005711:0.012508:0.013181:0.005330:0.009073:0.006042:0.012604:0.005792:-0.562785
®:@0.728321:0.767508:0.736701:0.767508:0.736701:0.758323:0.728321:0.758323:0.008380
use for the treatment of hypercalcaemic :@0.521745:0.789293:0.921014:0.789293:0.921014:0.773538:0.521745:0.773538:0.011699:0.007466:0.012508:0.008005:0.006042:0.012604:0.005792:0.007988:0.006523:0.011738:0.012508:0.007989:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007988:0.012604:0.006042:0.007991:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.012450:0.005330
emergencies, along with other  appropri-:@0.521745:0.805460:0.915682:0.805460:0.915682:0.789704:0.521745:0.789704:0.012508:0.018049:0.012508:0.005804:0.012950:0.012508:0.011738:0.012450:0.003848:0.012508:0.007466:0.005330:0.009467:0.013143:0.003848:0.012604:0.011738:0.012950:0.009467:0.015990:0.003848:0.006523:0.011738:0.009467:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330:0.004127:0.013143:0.013123:0.013123:0.005719:0.012604:0.013123:0.005792:0.003848:0.006388
ate agents, when a rapid decrease in se-:@0.521745:0.821626:0.915674:0.821626:0.915674:0.805870:0.521745:0.805870:0.013143:0.006523:0.012508:0.006639:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.006639:0.015990:0.011738:0.012508:0.011738:0.006639:0.013143:0.006639:0.005792:0.013143:0.013123:0.003848:0.013181:0.006639:0.013181:0.012508:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.006639:0.003848:0.011738:0.006639:0.007466:0.012508:0.006388
rum calcium concentration is required.:@0.521745:0.837792:0.882666:0.837792:0.882666:0.822036:0.521745:0.822036:0.005792:0.011699:0.018049:0.005330:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.005330:0.012450:0.012604:0.011738:0.012450:0.012508:0.011738:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.003848:0.007466:0.005330:0.005686:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.005330
SUPERIOR VENA CAVA SYNDROME:@0.521746:0.870465:0.873241:0.870465:0.873241:0.852649:0.521746:0.852649:0.011118:0.013683:0.011973:0.011118:0.012401:0.005987:0.017960:0.012401:0.005987:0.014966:0.011118:0.015822:0.015822:0.005987:0.016677:0.015822:0.014966:0.015822:0.005987:0.011118:0.013256:0.015822:0.014966:0.012401:0.017960:0.019242:0.011118
Superior vena cava (SVC) syndrome results :@0.521746:0.887780:0.921016:0.887780:0.921016:0.872024:0.521746:0.872024:0.009583:0.011699:0.013123:0.012508:0.005792:0.003848:0.012604:0.005792:0.004353:0.010660:0.012508:0.011738:0.013143:0.004368:0.012450:0.013143:0.010660:0.013143:0.004368:0.007100:0.009583:0.013508:0.015644:0.007100:0.004368:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.004355:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.005330
from obstruction of the SVC by invasion or :@0.521746:0.903946:0.921041:0.903946:0.921041:0.888190:0.521746:0.888190:0.006042:0.005711:0.012604:0.018049:0.006023:0.012604:0.013123:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.006023:0.012604:0.006042:0.006023:0.006523:0.011738:0.012508:0.006023:0.009583:0.013508:0.015644:0.006023:0.013123:0.010314:0.006023:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.012604:0.011738:0.006023:0.012604:0.005792:0.005330
compression of an adjacent pathologi-:@0.521746:0.920112:0.915692:0.920112:0.915692:0.904356:0.521746:0.904356:0.012450:0.012604:0.018049:0.013123:0.005711:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.012373:0.012604:0.006042:0.012373:0.013143:0.011738:0.012373:0.013143:0.013181:0.003906:0.013143:0.012450:0.012508:0.011738:0.006523:0.012373:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.006388
cal process which involves the right lung, :@0.521746:0.936278:0.921018:0.936278:0.921018:0.920522:0.521746:0.920522:0.012450:0.013143:0.003848:0.007812:0.013123:0.005715:0.012604:0.012450:0.012508:0.007466:0.007466:0.007812:0.015990:0.011738:0.003848:0.012450:0.011738:0.007812:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.007466:0.007824:0.006523:0.011738:0.012508:0.007812:0.005792:0.003848:0.012950:0.011738:0.006523:0.007812:0.003848:0.011699:0.011738:0.012950:0.005330:0.005330
YOUR CONSULTING PATHOLOGISTS:@1.249393:0.961848:1.664729:0.961848:1.664729:0.938742:1.249393:0.938742:0.015522:0.020696:0.015993:0.014581:0.007526:0.019285:0.020696:0.018344:0.013170:0.015993:0.011289:0.010819:0.007526:0.018344:0.020696:0.007526:0.014111:0.018344:0.010819:0.016933:0.020696:0.011289:0.020696:0.020696:0.007526:0.013170:0.010819:0.012230
bona:@1.187968:0.515264:1.525352:0.515264:1.525352:0.394702:1.187968:0.394702:0.087489:0.084025:0.078252:0.087617
“Bona:@1.108433:0.346989:1.496360:0.346989:1.496360:0.226427:1.108433:0.226427:0.064398:0.073634:0.084025:0.078252:0.087617
diagnosis:@1.269171:0.431126:1.844134:0.431126:1.844134:0.310565:1.269171:0.310565:0.087874:0.025657:0.087617:0.086334:0.078252:0.084025:0.049774:0.025657:0.049774
We translate the facts:@1.197348:0.655956:1.775033:0.655956:1.775033:0.601385:1.197348:0.601385:0.049992:0.035550:0.015553:0.016664:0.017775:0.036661:0.033328:0.024440:0.013331:0.036661:0.016664:0.035550:0.015553:0.016664:0.033328:0.035550:0.015553:0.015553:0.036661:0.035550:0.016664:0.024440
To initiate specialised tests or to discuss :@1.186383:0.768063:1.794828:0.768063:1.794828:0.737922:1.186383:0.737922:0.013662:0.021006:0.008884:0.006414:0.019563:0.006414:0.010872:0.006414:0.021904:0.010872:0.020846:0.008884:0.012443:0.021872:0.020846:0.020750:0.006414:0.021904:0.006414:0.006414:0.012443:0.020846:0.021968:0.008884:0.010872:0.020846:0.012443:0.010872:0.012443:0.008884:0.021006:0.009653:0.008884:0.010872:0.021006:0.008884:0.021968:0.006414:0.012443:0.020750:0.019499:0.012443:0.012443:0.008884
specific needs with an expert pathologist, :@1.163164:0.794521:1.818111:0.794521:1.818111:0.764381:1.163164:0.764381:0.012443:0.021872:0.020846:0.020750:0.006414:0.007809:0.007809:0.020750:0.008884:0.019563:0.020846:0.020846:0.021968:0.012443:0.008884:0.026651:0.006414:0.010872:0.019563:0.008884:0.021904:0.019563:0.008884:0.020846:0.015394:0.021872:0.020846:0.009653:0.010872:0.008884:0.021872:0.021904:0.010872:0.019563:0.021006:0.006414:0.021006:0.021584:0.006414:0.012443:0.010872:0.008884:0.008884
please visit :@1.246484:0.820979:1.422488:0.820979:1.422488:0.790839:1.246484:0.790839:0.021872:0.006414:0.020846:0.021904:0.012443:0.020846:0.008884:0.017767:0.006414:0.012443:0.006414:0.010872:0.008884
www.ampath.co.za:@1.422520:0.820979:1.725908:0.820979:1.725908:0.789472:1.422520:0.789472:0.025657:0.025657:0.025657:0.008980:0.021167:0.030146:0.021167:0.021167:0.009621:0.019242:0.008980:0.020525:0.020525:0.008980:0.014753:0.021167
curatio”*:@1.368119:0.588124:1.925123:0.588124:1.925123:0.467562:1.368119:0.467562:0.082999:0.077996:0.038613:0.087617:0.043488:0.025657:0.084025:0.062089:0.054520
*Good Diagnosis, Good Cure.:@1.279580:0.694122:1.678710:0.694122:1.678710:0.666816:1.279580:0.666816:0.012230:0.023347:0.017789:0.017789:0.018344:0.007782:0.019456:0.006671:0.018344:0.018344:0.016677:0.017789:0.012230:0.006671:0.012230:0.007782:0.007782:0.023347:0.017789:0.017789:0.018344:0.007782:0.021680:0.016677:0.008894:0.017789:0.007782
MIMS 2018.indd   1:@1.025369:1.026925:1.128047:1.026925:1.128047:1.015028:1.025369:1.015028:0.011430:0.004374:0.011430:0.006081:0.002912:0.006158:0.006158:0.006158:0.006158:0.002925:0.003438:0.007017:0.006773:0.006773:0.002912:0.002912:0.002912:0.006158
2018/05/14   03:19:51 PM:@1.850049:1.026925:1.980897:1.026925:1.980897:1.015028:1.850049:1.015028:0.006158:0.006158:0.006158:0.006158:0.004246:0.006158:0.006158:0.004246:0.006158:0.006158:0.002912:0.002912:0.002912:0.006158:0.006158:0.002925:0.006158:0.006158:0.002925:0.006158:0.006158:0.002912:0.007222:0.011430